ACUTA CAPITAL PARTNERS, LLC - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 116 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
ACUTA CAPITAL PARTNERS, LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2017$2,360,000
-21.1%
250,000
-47.1%
0.56%
-50.1%
Q3 2016$2,990,000
+57.9%
472,370
+5.2%
1.12%
+23.4%
Q2 2016$1,894,000
+86.6%
448,885
+92.8%
0.91%
+60.2%
Q1 2016$1,015,000–232,800–0.57%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q3 2016.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders